Juvenile idiopathic arthritis
(Redirected from Juvenile Idiopathic Arthritis)
Juvenile Idiopathic Arthritis[edit | edit source]
Juvenile Idiopathic Arthritis (JIA) is a type of arthritis that occurs in children aged 16 or younger. It is characterized by persistent joint inflammation, which can lead to joint damage and other complications if not treated effectively.
Classification[edit | edit source]
Juvenile Idiopathic Arthritis is classified into several subtypes based on symptoms, number of joints involved, and the presence of certain antibodies. The main subtypes include:
- Oligoarticular JIA: Involves four or fewer joints in the first six months of the disease.
- Polyarticular JIA: Affects five or more joints in the first six months and can be rheumatoid factor positive or negative.
- Systemic JIA: Characterized by arthritis, fever, and rash.
- Enthesitis-related arthritis: Involves inflammation of the entheses, the sites where tendons or ligaments insert into the bone.
- Psoriatic arthritis: Associated with psoriasis, a skin condition.
Symptoms[edit | edit source]
The symptoms of Juvenile Idiopathic Arthritis can vary depending on the subtype but generally include:
- Joint pain and swelling
- Stiffness, especially in the morning
- Fever and rash (in systemic JIA)
- Fatigue
- Reduced range of motion
Diagnosis[edit | edit source]
Diagnosing JIA involves a combination of clinical evaluation, laboratory tests, and imaging studies. Key diagnostic criteria include:
- Persistent arthritis in one or more joints for at least six weeks
- Exclusion of other causes of arthritis
- Laboratory tests such as antinuclear antibody (ANA), rheumatoid factor (RF), and HLA-B27
- Imaging studies like X-ray or MRI to assess joint damage
Treatment[edit | edit source]
The treatment of Juvenile Idiopathic Arthritis aims to control symptoms, prevent joint damage, and maintain function. Treatment options include:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation
- Disease-modifying antirheumatic drugs (DMARDs) such as methotrexate
- Biologic agents like tumor necrosis factor inhibitors
- Corticosteroids for severe inflammation
- Physical therapy to maintain joint function
Prognosis[edit | edit source]
The prognosis for children with Juvenile Idiopathic Arthritis varies. Some children may experience remission, while others may have persistent symptoms into adulthood. Early diagnosis and treatment are crucial for improving outcomes.
Complications[edit | edit source]
Potential complications of JIA include:
- Joint damage and deformity
- Growth disturbances
- Uveitis, an inflammation of the eye
- Osteoporosis due to prolonged corticosteroid use
See Also[edit | edit source]
External Links[edit | edit source]
- [Juvenile Idiopathic Arthritis Foundation]
- [American College of Rheumatology]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Kondreddy Naveen, Prab R. Tumpati, MD